TipRanks
Go Ultimate55% OFF

Urologix (ULGX) Financial Statements

Urologix Financial Overview

Urologix's market cap is currently $22. The company's EPS TTM is ―; its P/E ratio is 0.00; Urologix has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 14Jun 13Jun 12Jun 11Jun 10
Income Statement
Total Revenue―――――
Gross Profit$ 6.09M$ 8.18M$ 8.38M$ 6.54M$ 8.20M
Operating Income$ -4.00M$ -4.53M$ -4.14M$ -3.73M$ -2.26M
EBITDA$ -3.41M$ -3.86M$ -3.45M$ -3.16M$ -1.46M
Net Income$ -7.61M$ -4.29M$ -4.70M$ -3.73M$ -2.17M
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 5.67M$ 12.53M$ 12.68M$ 6.76M$ 10.20M
Total Debt$ 5.33M$ 5.33M$ 0.00$ 0.00$ 0.00
Net Debt$ 4.62M$ 3.04M$ -1.90M$ -3.06M$ -5.70M
Total Liabilities$ 12.64M$ 12.11M$ 12.05M$ 1.92M$ 2.00M
Stockholders' Equity―――――
Cash Flow
Free Cash Flow$ -1.57M$ -2.07M$ -770.00K$ -2.64M$ -1.34M
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD